We are delighted to announce that CDDF’s new white paper, Challenges and Potential Solutions to Advance Global Cancer Drug Development, has been published in the journal Therapeutic Innovation & Regulatory Science.
This paper reflects on multi-stakeholder discussions during the CDDF Annual Conference 2025 and provides key recommendations. The article highlights that a concerted effort from all stakeholders is urgently needed to accelerate the availability of life-saving, innovative cancer therapies—with improved toxicity profiles and quality of life (QoL)—to patients in need.
We would like to extend our sincere thanks to the co-authors for their invaluable contributions and expertise:
Axel Glasmacher, Bruno Paiva, Kim Lyerly, Birgit Wolf, Pio Zapella, Lidia Zielinska, Emma Clark, Murielle Mauer, Anja Schiel, Fergus Sweeney, Carin A. Uyl-de Groot, Marie von Lilienfeld-Toal & Jaap Verweij.